Alzheimers

We thank J&J for their leadership as they announced new efforts to combat Alzheimer’s disease, specifically their vaccine trial. In taking on this tau antibody and a tau-targeting vaccine, J&J is bringing hope to those impacted by Alzheimer’s disease, and addressing the need for cutting-edge research by launching this exciting trial. We are grateful for […]

Atlanta News First- By Sawyer Buccy Published: Nov. 29, 2023 at 4:51 PM EST|Updated: 15 hours ago ATLANTA, Ga. (Atlanta News First) – You probably know someone whose life has been impacted in one way or another by Alzheimer’s. Some people are fighting to find ways to slow the progression of the disease through clinical trials. One Georgia […]

By JOANN GREER November 18, 2023 at 5:30 a.m. My husband and I know first-hand the toll that Alzheimer’s Disease has as we have cared for a mom and stepfather who lived with Alzheimer’s Disease before they passed away. With it being National Alzheimer’s Disease Awareness Month and National Family Caregiver’s Month, we would like to […]

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida take Alzheimer’s Disease clinical research on the road By Staff | Oct 4, 2023 Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida will be driving clinical research into the community as they introduce the Memory Machine to Fort Myers. The new Memory Machine will allow […]

A new seven-figure ad campaign takes aim – again – at Medicare’s pending coverage decision on Alzheimer’s disease anti-amyloid drugs. UsAgainstAlzheimer’s launched the $1 million-plus national effort Sunday, including a TV ad that ran across the the day’s morning talk news shows. The group is the latest to push back on the Centers for Medicare […]

At a pivotal time in Alzheimer’s research, the GAP Foundation and the Alzheimer’s Drug Discovery Foundation will connect funders with leading innovators Updated on March 26, 2020: The Global Alzheimer’s Platform Foundation (GAP) has announced it is postponing the GAP Innovation Summit that was to be held on May 5, 2020 with our partner, the […]

For the first time in 15 years, there are new Alzheimer’s drug treatments on the horizon that are expected to seek regulatory approval by the FDA and leading experts are increasely optimistic that a major breakthrough in Alzheimer’s research will occur within the next five years. We are at a moment of peak opportunity – […]